AstraZeneca Shares Up 4% On WHO's Emergency Use Approval Of Covid-19 Vaccine
Edited by Nirmalya Sen | Tuesday February 16, 2021WHO's move widens access to the relatively inexpensive shot in the developing world
Dr. Reddy's Laboratories Q3 Profit At Rs 20 Crore
Edited by Nirmalya Sen | Friday January 29, 2021Revenue for the third quarter came at Rs 4,930 crore, which was up 12 per cent year-over-year and 1 per cent quarter-over-quarter
Sun Pharma Q3 Profit Doubles To Rs 1,852.5 Crore
Edited by Nirmalya Sen | Friday January 29, 2021The pharma major reported a net profit of Rs 1,852.5 crore in Q3FY21
Novavax Claims Covid-19 Vaccine 89% Effective In UK Trial, Less In South Africa, Shares Jump
Edited by Nirmalya Sen | Friday January 29, 2021Serum Institute Of India has applied to conduct local trial for Novavax vaccine
Dr. Reddy's Ends Review Of Covid-19 Drug Avigan In Kuwait
Edited by Nirmalya Sen | Wednesday January 27, 2021Fujifilm, Dr. Reddy's and GRA had entered into a deal in July to sell Avigan globally excluding Japan, China and Russia
Moderna Believes Vaccine Will Work Against New Variants
Edited by Nirmalya Sen | Tuesday January 26, 2021Moderna Covid-19 Vaccine: The emergence of new variants in Britain, South Africa and Brazil has created some concern that mutations in the virus may make vaccines less effective
Will Receive Two Million AstraZeneca Doses By Friday From India: Brazil
Edited by Nirmalya Sen | Friday January 22, 2021The announcement comes amid delays in receiving the vaccine from India, the latest in a series of miscues surrounding the country's inoculations drive
India Will Start Commercial Vaccine Exports With Shipments to Morocco, Brazil
Edited by Nirmalya Sen | Friday January 22, 2021Serum Institute of India will also send the Covid-19 vaccine to South Africa and Saudi Arabia
South Africa To Pay $5.25 Per Dose For AstraZeneca Vaccine From India's SII
Edited by Nirmalya Sen | Thursday January 21, 2021South Africa is hosting clinical trials of the vaccine developed by AstraZeneca in partnership with Oxford University, raising questions about the higher price it will be paying
Serum Institute Awaits WHO Emergency Approval For AstraZeneca Shot Soon
Edited by Nirmalya Sen | Thursday January 14, 2021The World Health Organization (WHO) listed Pfizer and BioNTech's Covid-19 shot for emergency use on December 31 as it sought to accelerate vaccination in the developing world, which is badly lagging Western countries
Dr.Reddy's Says Sputnik V Covid-19 Vaccine Safe In India Mid-stage Trial
Edited by Nirmalya Sen | Monday January 11, 2021The company has submitted the mid-stage trial safety data to India's drug regulator for review and approval to continue late-stage trials
AstraZeneca's Covid-19 Vaccine Set To Become First One Approved In India: Report
Edited by Nirmalya Sen | Friday January 01, 2021Britain and Argentina have already authorised the vaccine for urgent public use
Regeneron Claims Its Covid-19 Antibody Therapy Demonstrated Promise in Hospitalised Patients
Edited by Nirmalya Sen | Wednesday December 30, 2020Casirivimab and imdevimab are not authorised for use in patients who are hospitalised or require oxygen therapy due to Covid-19, or for people currently using chronic oxygen therapy because of an underlying comorbidity
India Dry Runs Vaccine Delivery Systems Ahead Of Emergency Approval
Edited by Nirmalya Sen | Monday December 28, 2020Covid-19 Vaccine: India aims to deliver 600 million coronavirus shots over the next six to eight months starting in January
Turkey Says China's Sinovac Covid-19 Vaccine, CoronaVac, 91.25% Effective In Late Trials
Edited by Nirmalya Sen | Friday December 25, 2020Sinovac Covid-19 Vaccine: Turkish researchers said no major side-effects were seen during their trial, apart from one person who had an allergic reaction
